The biotech sector has been hit hard in Oct after spending most of Aug & Sept in a tight trading range after a huge surge in July. The main biotech indices have lost over 10% of their value from recent highs in what has been a brutal and indiscriminate decline. A main trigger for this huge shift of sentiment is politics. Mais
